Peptide profile
Published Data as of
PepBank holds 2 publications with 7 findings in people for GHK-Cu, as of October 30, 2026.1 It holds 18 publications with findings in animals and 30 with laboratory findings.1 In a randomized trial in patients after laser skin resurfacing, wrinkles improved with no difference between groups.2 On a questionnaire, skin quality improved significantly more in patients using GHK-Cu.2 PepBank's regulatory record lists GHK-Cu as not approved for any use.3
As of October 30, 2026, PepBank holds 2 publications with 7 findings in people for GHK-Cu.1 The trial registry records in PepBank show 1 registered trial that tests GHK-Cu.1 PepBank holds 41 GHK-Cu studies with results where GHK-Cu was the given peptide. Together they report 226 results.1
PepBank also holds 18 publications with 123 findings in animals.1 It holds 30 publications with 95 laboratory findings in cells or tissue.1 It also holds 1 publication with 1 finding predicted by a computer model.1
One study in people is a randomized trial in patients after carbon dioxide laser skin resurfacing.2 For patients in that trial, topical GHK-Cu did not clear redness (erythema) any earlier than a regimen without GHK-Cu.2
Wrinkles improved in all patients in the trial, with no difference between the GHK-Cu and no-GHK-Cu groups.2 Overall skin quality also improved in all patients in the trial, again with no difference between groups.2 On the questionnaire, though, patients using GHK-Cu in the trial showed a significantly greater improvement in overall skin quality.2
A systematic review of clinical studies in people reported that GHK-Cu significantly reduced wrinkle depth compared with controls.4 The same review of clinical studies in people reported a significant reduction in wrinkle volume compared with controls.4 The review also reported that GHK-Cu improved patient-reported satisfaction in patients after laser resurfacing.4
In rats with wound chambers, GHK-Cu injection increased collagen content, and higher concentrations gave larger increases.5 In the same rats, GHK-Cu increased type I and type III collagen mRNA.5
In mice with bleomycin-induced pulmonary fibrosis, GHK-Cu reduced collagen deposition.6 In mice with lung injury from lipopolysaccharide (LPS), GHK-Cu attenuated lung tissue changes and suppressed inflammatory cell infiltration into the lung.7
In mice with scald wounds, angiogenesis in burned skin was better with GHK-Cu in liposomes than with free GHK-Cu.8 In rats with irradiated skin flaps, topical GHK-Cu gel did not significantly change mean ischemic area compared with control at the P < .01 threshold.9
A systematic review of clinical studies in people reported that GHK-Cu significantly reduced wrinkle depth compared with controls.4 The same review in people reported a significant reduction in wrinkle volume compared with controls.4 In a randomized trial in patients after laser resurfacing, all patients improved in wrinkles, with no difference between the GHK-Cu and no-GHK-Cu groups.2
The trial registry records in PepBank show 1 registered trial that tests GHK-Cu, as of October 30, 2026.1 One published study in people is a randomized trial in patients after carbon dioxide laser skin resurfacing.2 In that trial in patients, a questionnaire showed significantly greater improvement in overall skin quality with GHK-Cu.2
Among the peptides in PepBank, GHK-Cu has 41 studies with results where it was the given peptide, as of October 30, 2026.1 Those studies hold 226 results.1 PepBank holds 2 publications with findings in people, 18 with findings in animals and 30 with laboratory findings.1
In a randomized trial in patients after carbon dioxide laser resurfacing, topical GHK-Cu did not clear redness earlier than a regimen without it.2 Overall skin quality improved in all patients in the trial, with no difference between groups.2 A systematic review reported that GHK-Cu improved patient-reported satisfaction in patients after laser resurfacing.4
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated